000640.KS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 02:30):

Stats
Today's Volume	1 719.00
Average Volume	8 527.00
Market Cap	712.58B
EPS	KRW0 ( 2024-02-13 )
Next earnings date	( KRW2 308.93 ) 2024-05-05
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW44.84 (0.04%)

Volume Correlation

Long: 0.27 (neutral)

Short: 0.96 (very strong)

Signal:(83.494) Expect same movement, but be aware

Dong-A Socio Holdings Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Dong-A Socio Holdings Correlation - Currency/Commodity

0.52
( weak )

0.40
( neutral )

-0.06
( neutral )

-0.09
( neutral )

0.58
( weak )

-0.03
( neutral )

Dong-A Socio Holdings Financials

Annual	2023
Revenue:	KRW1 131.86B
Gross Profit:	KRW363.97B (32.16 %)
EPS:	KRW9 277.25

Q4	2023
Revenue:	KRW302.35B
Gross Profit:	KRW64.48B (21.33 %)
EPS:	KRW2 461.77

Q3	2023
Revenue:	KRW289.23B
Gross Profit:	KRW101.85B (35.21 %)
EPS:	KRW3 777.34

Q2	2023
Revenue:	KRW284.89B
Gross Profit:	KRW96.95B (34.03 %)
EPS:	KRW3 487.42

Financial Reports:

No articles found.

Dong-A Socio Holdings

Dong-A Socio Holdings Co., Ltd. engages in the pharmaceutical business in South Korea and internationally. It offers Bacchus, Benachio, and Tempo; infection management products; imaging equipment, such as FX-V1 and CLS-S7 for surgery and diagnosis; and MEDIFLIX, a medical knowledge-sharing platform. The company provides business management services; CMO services, including pre-clinical study, clinical trial, and commercial production of antibodies and recombinant proteins; maintenance, repair, and operation; quarantine; and military logistics services; and packaging and parcel delivery services. In addition, it offers mineral water under the Gayasan Cheonnyeonsu brand; POCARI SWEAT; Narangd cider; Oronamin C; Oran-C bio-PET; and STP2104, an mRNA based COVID-19 vaccine, which is in phase I clinical trial. Further, the company engages in the construction of industrial facilities, such as bio, pharmaceutical, food, logistics warehouses, education/research facilities, work/sales facilities, and public facilities; provides design, maintenance, and asset development services. Additionally, it provides IT systems development and maintenance. The company was founded in 1932 and is headquartered in Seoul, South Korea.